rs181517869
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4BP6BS2_Supporting
The NM_004006.3(DMD):c.9580A>C(p.Ile3194Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000157 in 1,207,558 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004006.3 missense
Scores
Clinical Significance
Conservation
Publications
- Becker muscular dystrophyInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
- dilated cardiomyopathy 3BInheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
- Duchenne and Becker muscular dystrophyInheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- Duchenne muscular dystrophyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- progressive muscular dystrophyInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- symptomatic form of muscular dystrophy of Duchenne and Becker in female carriersInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DMD | ENST00000357033.9 | c.9580A>C | p.Ile3194Leu | missense_variant | Exon 66 of 79 | 1 | NM_004006.3 | ENSP00000354923.3 |
Frequencies
GnomAD3 genomes AF: 0.0000715 AC: 8AN: 111962Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.0000223 AC: 4AN: 179673 AF XY: 0.0000155 show subpopulations
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1095544Hom.: 0 Cov.: 31 AF XY: 0.0000166 AC XY: 6AN XY: 361040 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000714 AC: 8AN: 112014Hom.: 0 Cov.: 24 AF XY: 0.0000877 AC XY: 3AN XY: 34214 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Uncertain:1
- -
Duchenne muscular dystrophy;C0917713:Becker muscular dystrophy;C3668940:Dilated cardiomyopathy 3B Uncertain:1
- -
not provided Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.I3194L variant (also known as c.9580A>C), located in coding exon 66 of the DMD gene, results from an A to C substitution at nucleotide position 9580. The isoleucine at codon 3194 is replaced by leucine, an amino acid with highly similar properties. This variant was reported in individual(s) in a dilated cardiomyopathy (DCM) cohort (Janin A et al. Mol Diagn Ther, 2021 May;25:373-385). Based on data from gnomAD, the C allele has an overall frequency of 0.0025% (5/201607) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.0055% (5/90656) of European (non-Finnish) alleles. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Duchenne muscular dystrophy Benign:1
- -
Duchenne muscular dystrophy;C0917713:Becker muscular dystrophy Other:1
Variant interpreted as Uncertain significance and reported on 2/21/2020 by Lab or GTR ID 500057. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator John Constantino MD PhD from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at